Clinical Research News
-
CStone announces first patient dosed in China with BLU-667
Clinical Research | News | 0 Comment | 13 Aug, 2019
CStone Pharmaceuticals, on 13 August 2019, announced the dosing of the first patient in China for the Phase I ...Read more
-
Jazz Pharma advances recombinant crisantaspase development program
Clinical Research | News | 0 Comment | 08 Aug, 2019
Ireland based Jazz Pharmaceuticals plc has announced that the Phase 1 study of its recombinant crisantaspase molecu...Read more
-
DiscGenics treates First Patients in Japanese Clinical Trial of Cell Therapy for DDD
Clinical Research | News | 0 Comment | 08 Aug, 2019
DiscGenics, Inc., a US based clinical-stage biotechnology company focused on developing regenerative cell-based therapie...Read more
-
SillaJen to discontinue PHOCUS trial for advanced liver cancer
Clinical Research | News | 0 Comment | 06 Aug, 2019
SillaJen, Inc., a South Korea based clinical-stage, biotherapeutics company focused on the development of oncolytic immu...Read more
-
"Improving trial efficiency and lowering trial costs is a big challenge"
Clinical Research | Opinion | 0 Comment | 05 Aug, 2019
Historically, getting patients in clinical trials is the biggest challenge to healthcare breakthrough. But now data can ...Read more
-
Botanix receives commitments for A$40M in US-led institutional placement
Clinical Research | News | 0 Comment | 05 Aug, 2019
Australia headquartered Clinical stage cannabinoid company Botanix Pharmaceuticals has announced the receipt of firm com...Read more
-
Veristat expands operations into Taiwan
Clinical Research | News | 0 Comment | 01 Aug, 2019
US headquartered Veristat, a scientifically oriented clinical development, and regulatory submission partner, announces ...Read more
-
CStone to initiate ivosidenib Phase I study in China
Clinical Research | News | 0 Comment | 22 Jul, 2019
CStone Pharmaceuticals has received approval from China National Medical Products Administration (NMPA) to initiate a Ph...Read more
-
Kazia to use drug with radiotherapy for brain cancer treatment
Clinical Research | News | 0 Comment | 23 Jul, 2019
Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company, is pleased to announce that Memorial S...Read more
-
SOTIO initiates first-in-human clinical trial with IL-15 superagonist SO-C101
Clinical Research | News | 0 Comment | 12 Jul, 2019
SOTIO and Cytune Pharma, members of the PPF Group have announced that the first dosing of cancer patients with ...Read more
-
CStone announces first patient dosed in China with avapritinib for advanced GIST
Clinical Research | News | 0 Comment | 10 Jul, 2019
CStone Pharmaceuticals, on 9 July 2019, announced in Suzhou, China that the first patient has been dosed in Ch...Read more
-
Clinical Research | News | 0 Comment | 08 Jul, 2019
Sangamo Therapeutics, a genomic medicine company, and Pfizer has announced updated results from the Phase 1/2 ...Read more
-
Takeda announces results from Phase IIIb/IV clinical trial for ADYNOVATE
Clinical Research | News | 0 Comment | 08 Jul, 2019
Takeda, an R&D-driven, global biopharmaceutical company with a leadership position in rare diseases has announced up...Read more
-
Sommetrics completes study of new sleep apnea treatment in ethnic Japanese subjects
Clinical Research | News | 0 Comment | 26 Jun, 2019
Sommetrics, a company dedicated to developing state of the art products to treat obstructive sleep apnea (OSA) has annou...Read more
-
FDA Grants Orphan Drug Designation to XWL-008 to treat Narcolepsy
Clinical Research | News | 0 Comment | 25 Jun, 2019
XW Laboratories Inc., a China headquartered clinical-stage biopharmaceutical company pioneering the discovery of novel s...Read more
-
Prestige Biopharma reports Ph III results for Tuznue
Clinical Research | News | 0 Comment | 24 Jun, 2019
Prestige BioPharma has announced positive top-line results from a Phase III global clinical trial (Troika) evaluati...Read more
-
Parexel launches an enhanced integrated outsourcing delivery model for FSP
Clinical Research | News | 0 Comment | 24 Jun, 2019
Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to marke...Read more
-
Asieris Completes Enrolment for US APL-1202 Phase Ib Clinical Trial
Clinical Research | News | 0 Comment | 24 Jun, 2019
Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the t...Read more
